Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 May 9;92(10):4462–4466. doi: 10.1073/pnas.92.10.4462

A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity.

W S Yang 1, D N Nevin 1, R Peng 1, J D Brunzell 1, S S Deeb 1
PMCID: PMC41964  PMID: 7753827

Abstract

We have identified a naturally occurring mutation in the promoter of the lipoprotein lipase (LPL) gene. One of 20 patients with familial combined hyperlipidemia (FCHL) and reduced levels of postheparin plasma LPL activity was found to be a heterozygote carrier of this mutation. The mutation, a T-->C substitution at nt -39, occurred in the binding site of the transcription factor Oct-1. As a result, the transcriptional activity of the mutant promoter was < 15% of wild type, as determined by transfection studies in the human macrophage-like cell line THP-1. This decrease in promoter activity was observed in undifferentiated as well as in phorbol ester-differentiated THP-1 cells. Furthermore, the inductive effect of elevating the levels of intracellular cAMP was equally reduced. This mutation was not present among 20 FCHL patients with normal plasma LPL levels nor has it been reported among individuals with familial LPL deficiency. Thus, heterozygosity for LPL promoter mutations may be one of several factors that contribute to the etiology of FCHL.

Full text

PDF
4462

Images in this article

4464Fig. 1
on p.4464
4464Fig. 2
on p.4464
4464Fig. 3
on p.4464

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auwerx J. H., Deeb S., Brunzell J. D., Peng R., Chait A. Transcriptional activation of the lipoprotein lipase and apolipoprotein E genes accompanies differentiation in some human macrophage-like cell lines. Biochemistry. 1988 Apr 19;27(8):2651–2655. doi: 10.1021/bi00408a003. [DOI] [PubMed] [Google Scholar]
  2. Auwerx J. H., Deeb S., Brunzell J. D., Wolfbauer G., Chait A. Lipoprotein lipase gene expression in THP-1 cells. Biochemistry. 1989 May 30;28(11):4563–4567. doi: 10.1021/bi00437a009. [DOI] [PubMed] [Google Scholar]
  3. Auwerx J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia. 1991 Jan 15;47(1):22–31. doi: 10.1007/BF02041244. [DOI] [PubMed] [Google Scholar]
  4. Babirak S. P., Brown B. G., Brunzell J. D. Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler Thromb. 1992 Oct;12(10):1176–1183. doi: 10.1161/01.atv.12.10.1176. [DOI] [PubMed] [Google Scholar]
  5. Babirak S. P., Iverius P. H., Fujimoto W. Y., Brunzell J. D. Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis. 1989 May-Jun;9(3):326–334. doi: 10.1161/01.atv.9.3.326. [DOI] [PubMed] [Google Scholar]
  6. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  7. Brindle P. K., Montminy M. R. The CREB family of transcription activators. Curr Opin Genet Dev. 1992 Apr;2(2):199–204. doi: 10.1016/s0959-437x(05)80274-6. [DOI] [PubMed] [Google Scholar]
  8. Brunzell J. D., Albers J. J., Chait A., Grundy S. M., Groszek E., McDonald G. B. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res. 1983 Feb;24(2):147–155. [PubMed] [Google Scholar]
  9. Brunzell J. D., Schrott H. G., Motulsky A. G., Bierman E. L. Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism. 1976 Mar;25(3):313–320. doi: 10.1016/0026-0495(76)90089-5. [DOI] [PubMed] [Google Scholar]
  10. Comb M., Goodman H. M. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res. 1990 Jul 11;18(13):3975–3982. doi: 10.1093/nar/18.13.3975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cooper D. A., Lu S. C., Viswanath R., Freiman R. N., Bensadoun A. The structure and complete nucleotide sequence of the avian lipoprotein lipase gene. Biochim Biophys Acta. 1992 Jan 6;1129(2):166–171. doi: 10.1016/0167-4781(92)90482-f. [DOI] [PubMed] [Google Scholar]
  12. Crossley M., Brownlee G. G. Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Nature. 1990 May 31;345(6274):444–446. doi: 10.1038/345444a0. [DOI] [PubMed] [Google Scholar]
  13. Currie R. A., Eckel R. H. Characterization of a high affinity octamer transcription factor binding site in the human lipoprotein lipase promoter. Arch Biochem Biophys. 1992 Nov 1;298(2):630–639. doi: 10.1016/0003-9861(92)90459-a. [DOI] [PubMed] [Google Scholar]
  14. Deeb S. S., Peng R. L. Structure of the human lipoprotein lipase gene. Biochemistry. 1989 May 16;28(10):4131–4135. doi: 10.1021/bi00436a001. [DOI] [PubMed] [Google Scholar]
  15. Efremov D. G., Dimovski A. J., Huisman T. H. The -158 (C-->T) promoter mutation is responsible for the increased transcription of the 3' gamma gene in the Atlanta type of hereditary persistence of fetal hemoglobin. Blood. 1994 Jun 1;83(11):3350–3355. [PubMed] [Google Scholar]
  16. Falkner F. G., Zachau H. G. Correct transcription of an immunoglobulin kappa gene requires an upstream fragment containing conserved sequence elements. Nature. 1984 Jul 5;310(5972):71–74. doi: 10.1038/310071a0. [DOI] [PubMed] [Google Scholar]
  17. Gagné C., Brun L. D., Julien P., Moorjani S., Lupien P. J. Primary lipoprotein-lipase-activity deficiency: clinical investigation of a French Canadian population. CMAJ. 1989 Feb 15;140(4):405–411. [PMC free article] [PubMed] [Google Scholar]
  18. Gagné E., Genest J., Jr, Zhang H., Clarke L. A., Hayden M. R. Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia. Arterioscler Thromb. 1994 Aug;14(8):1250–1257. doi: 10.1161/01.atv.14.8.1250. [DOI] [PubMed] [Google Scholar]
  19. Genest J. J., Jr, Martin-Munley S. S., McNamara J. R., Ordovas J. M., Jenner J., Myers R. H., Silberman S. R., Wilson P. W., Salem D. N., Schaefer E. J. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation. 1992 Jun;85(6):2025–2033. doi: 10.1161/01.cir.85.6.2025. [DOI] [PubMed] [Google Scholar]
  20. Goldstein J. L., Schrott H. G., Hazzard W. R., Bierman E. L., Motulsky A. G. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973 Jul;52(7):1544–1568. doi: 10.1172/JCI107332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Herr W., Sturm R. A., Clerc R. G., Corcoran L. M., Baltimore D., Sharp P. A., Ingraham H. A., Rosenfeld M. G., Finney M., Ruvkun G. The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev. 1988 Dec;2(12A):1513–1516. doi: 10.1101/gad.2.12a.1513. [DOI] [PubMed] [Google Scholar]
  22. Hua X. X., Enerbäck S., Hudson J., Youkhana K., Gimble J. M. Cloning and characterization of the promoter of the murine lipoprotein lipase-encoding gene: structural and functional analysis. Gene. 1991 Nov 15;107(2):247–258. doi: 10.1016/0378-1119(91)90325-6. [DOI] [PubMed] [Google Scholar]
  23. Jarvik G. P., Brunzell J. D., Austin M. A., Krauss R. M., Motulsky A. G., Wijsman E. Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype. Arterioscler Thromb. 1994 Nov;14(11):1687–1694. doi: 10.1161/01.atv.14.11.1687. [DOI] [PubMed] [Google Scholar]
  24. Klemm J. D., Rould M. A., Aurora R., Herr W., Pabo C. O. Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell. 1994 Apr 8;77(1):21–32. doi: 10.1016/0092-8674(94)90231-3. [DOI] [PubMed] [Google Scholar]
  25. Koivisto U. M., Palvimo J. J., Jänne O. A., Kontula K. A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10526–10530. doi: 10.1073/pnas.91.22.10526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kretz K. A., Carson G. S., O'Brien J. S. Direct sequencing from low-melt agarose with Sequenase. Nucleic Acids Res. 1989 Jul 25;17(14):5864–5864. doi: 10.1093/nar/17.14.5864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Laakso M., Malkki M., Kekäläinen P., Kuusisto J., Deeb S. S. Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J Clin Invest. 1994 Sep;94(3):1141–1146. doi: 10.1172/JCI117429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lee W., Mitchell P., Tjian R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell. 1987 Jun 19;49(6):741–752. doi: 10.1016/0092-8674(87)90612-x. [DOI] [PubMed] [Google Scholar]
  29. Liou H. C., Baltimore D. Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr Opin Cell Biol. 1993 Jun;5(3):477–487. doi: 10.1016/0955-0674(93)90014-h. [DOI] [PubMed] [Google Scholar]
  30. Lu S. C., Bensadoun A. Identification of the 5' regulatory elements of avian lipoprotein lipase gene: synergistic effect of multiple factors. Biochim Biophys Acta. 1993 Dec 14;1216(3):375–384. doi: 10.1016/0167-4781(93)90004-w. [DOI] [PubMed] [Google Scholar]
  31. Mitchell P. J., Timmons P. M., Hébert J. M., Rigby P. W., Tjian R. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev. 1991 Jan;5(1):105–119. doi: 10.1101/gad.5.1.105. [DOI] [PubMed] [Google Scholar]
  32. Nevin D. N., Brunzell J. D., Deeb S. S. The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity. Arterioscler Thromb. 1994 Jun;14(6):869–873. doi: 10.1161/01.atv.14.6.869. [DOI] [PubMed] [Google Scholar]
  33. Nikkilä E. A., Aro A. Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet. 1973 May 5;1(7810):954–959. doi: 10.1016/s0140-6736(73)91598-5. [DOI] [PubMed] [Google Scholar]
  34. Nordeen S. K. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques. 1988 May;6(5):454–458. [PubMed] [Google Scholar]
  35. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989 Nov;5(4):874–879. doi: 10.1016/0888-7543(89)90129-8. [DOI] [PubMed] [Google Scholar]
  36. Parslow T. G., Blair D. L., Murphy W. J., Granner D. K. Structure of the 5' ends of immunoglobulin genes: a novel conserved sequence. Proc Natl Acad Sci U S A. 1984 May;81(9):2650–2654. doi: 10.1073/pnas.81.9.2650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Previato L., Parrott C. L., Santamarina-Fojo S., Brewer H. B., Jr Transcriptional regulation of the human lipoprotein lipase gene in 3T3-L1 adipocytes. J Biol Chem. 1991 Oct 5;266(28):18958–18963. [PubMed] [Google Scholar]
  38. Roberts S. B., Segil N., Heintz N. Differential phosphorylation of the transcription factor Oct1 during the cell cycle. Science. 1991 Aug 30;253(5023):1022–1026. doi: 10.1126/science.1887216. [DOI] [PubMed] [Google Scholar]
  39. Rose H. G., Kranz P., Weinstock M., Juliano J., Haft J. I. Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype. Am J Med. 1973 Feb;54(2):148–160. doi: 10.1016/0002-9343(73)90218-0. [DOI] [PubMed] [Google Scholar]
  40. Segil N., Roberts S. B., Heintz N. Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA binding activity. Science. 1991 Dec 20;254(5039):1814–1816. doi: 10.1126/science.1684878. [DOI] [PubMed] [Google Scholar]
  41. Singh H., Sen R., Baltimore D., Sharp P. A. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature. 1986 Jan 9;319(6049):154–158. doi: 10.1038/319154a0. [DOI] [PubMed] [Google Scholar]
  42. Staudt L. M., Singh H., Sen R., Wirth T., Sharp P. A., Baltimore D. A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature. 1986 Oct 16;323(6089):640–643. doi: 10.1038/323640a0. [DOI] [PubMed] [Google Scholar]
  43. Tanaka M., Lai J. S., Herr W. Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. Cell. 1992 Feb 21;68(4):755–767. doi: 10.1016/0092-8674(92)90150-b. [DOI] [PubMed] [Google Scholar]
  44. Wilson D. E., Edwards C. Q., Chan I. F. Phenotypic heterogeneity in the extended pedigree of a proband with lipoprotein lipase deficiency. Metabolism. 1983 Dec;32(12):1107–1114. doi: 10.1016/0026-0495(83)90056-2. [DOI] [PubMed] [Google Scholar]
  45. Wilson D. E., Emi M., Iverius P. H., Hata A., Wu L. L., Hillas E., Williams R. R., Lalouel J. M. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest. 1990 Sep;86(3):735–750. doi: 10.1172/JCI114770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Wu H., Moulton K., Horvai A., Parik S., Glass C. K. Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene. Mol Cell Biol. 1994 Mar;14(3):2129–2139. doi: 10.1128/mcb.14.3.2129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. de Wet J. R., Wood K. V., DeLuca M., Helinski D. R., Subramani S. Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol. 1987 Feb;7(2):725–737. doi: 10.1128/mcb.7.2.725. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES